BRCA2 and hypoparathyroidism-retardation-dysmorphism syndrome: Molecular characteristics such as BRCA1 or BRCA2 mutational status, homologous recombination deficiency (HRD) or molecular subtypes based on gene expression signatures may impact prognosis [21, 22].